Volume 21, Issue 11, Pages (December 2017)

Slides:



Advertisements
Similar presentations
Volume 4, Issue 12, Pages (December 2015)
Advertisements

Higher Human Biology Unit 1 – Section 6 Metabolic Pathways
Control of Metabolic Pathways (2)
Volume 42, Issue 3, Pages (March 2015)
Volume 21, Issue 11, Pages (December 2017)
Volume 14, Issue 4, Pages (October 2011)
Volume 10, Issue 4, Pages (October 2009)
Volume 17, Issue 3, Pages (October 2016)
Rapamycin Suppresses Tumor Growth and Alters the Metabolic Phenotype in T-Cell Lymphoma  Wasakorn Kittipongdaja, Xuesong Wu, Justine Garner, Xiping Liu,
Volume 16, Issue 6, Pages (August 2016)
Volume 24, Issue 3, Pages (July 2018)
Volume 24, Issue 1, Pages (July 2016)
Volume 17, Issue 3, Pages (October 2016)
Volume 17, Issue 1, Pages (September 2016)
Volume 23, Issue 7, Pages (May 2018)
Volume 9, Issue 2, Pages (August 2017)
Volume 23, Issue 11, Pages (June 2018)
Volume 13, Issue 9, Pages (December 2015)
Volume 23, Issue 7, Pages (May 2018)
Volume 17, Issue 1, Pages (September 2016)
Volume 13, Issue 5, Pages (November 2015)
Volume 18, Issue 9, Pages (February 2017)
Volume 19, Issue 11, Pages (June 2017)
Anne L. Sapiro, Patricia Deng, Rui Zhang, Jin Billy Li  Cell Reports 
Understanding Tissue-Specific Gene Regulation
Volume 7, Issue 3, Pages (May 2014)
Volume 17, Issue 9, Pages (September 2010)
Volume 23, Issue 4, Pages (April 2016)
Volume 69, Issue 4, Pages e7 (February 2018)
Volume 35, Issue 6, Pages (December 2011)
Volume 162, Issue 3, Pages (July 2015)
Transcriptional Profiling of Quiescent Muscle Stem Cells In Vivo
Volume 17, Issue 8, Pages (November 2016)
Volume 3, Issue 1, Pages (January 2013)
Volume 23, Issue 7, Pages (May 2018)
Targeting Bacterial Central Metabolism for Drug Development
Volume 7, Issue 3, Pages (May 2014)
Volume 19, Issue 11, Pages (June 2017)
Volume 22, Issue 10, Pages (March 2018)
Volume 16, Issue 6, Pages (August 2016)
Volume 17, Issue 1, Pages (September 2016)
Volume 17, Issue 2, Pages (October 2016)
Volume 18, Issue 10, Pages (March 2017)
Volume 23, Issue 10, Pages (June 2018)
Volume 14, Issue 5, Pages (February 2016)
Modeling Developmental and Tumorigenic Aspects of Trilateral Retinoblastoma via Human Embryonic Stem Cells  Yishai Avior, Elyad Lezmi, Dorit Yanuka, Nissim.
Lynnea R. Waters, Fasih M. Ahsan, Dane M
Volume 21, Issue 4, Pages (April 2015)
Volume 23, Issue 5, Pages (May 2016)
Volume 22, Issue 11, Pages (March 2018)
Volume 22, Issue 2, Pages (January 2018)
Volume 17, Issue 6, Pages (November 2016)
High-Fat Diet Triggers Inflammation-Induced Cleavage of SIRT1 in Adipose Tissue To Promote Metabolic Dysfunction  Angeliki Chalkiadaki, Leonard Guarente 
Volume 17, Issue 3, Pages (October 2016)
Volume 15, Issue 2, Pages (February 2012)
Volume 24, Issue 6, Pages e4 (June 2017)
Volume 14, Issue 6, Pages (February 2016)
Volume 56, Issue 3, Pages (November 2014)
Volume 17, Issue 9, Pages (September 2010)
Marijn T.M. van Jaarsveld, Difan Deng, Erik A.C. Wiemer, Zhike Zi 
Shuai Jiang, Wei Yan, Shizhen Emily Wang, David Baltimore 
Volume 23, Issue 6, Pages (May 2018)
Unlikely partners in weight loss?
Volume 25, Issue 2, Pages e3 (October 2018)
Volume 26, Issue 8, Pages e7 (February 2019)
Adipose Fatty Acid Oxidation Is Required for Thermogenesis and Potentiates Oxidative Stress-Induced Inflammation  Jieun Lee, Jessica M. Ellis, Michael J.
Genome-wide Functional Analysis Reveals Factors Needed at the Transition Steps of Induced Reprogramming  Chao-Shun Yang, Kung-Yen Chang, Tariq M. Rana 
Volume 27, Issue 7, Pages e4 (May 2019)
Fig. 3 TDP1 promotes OXPHOS at basal and high ATP demands.
Volume 16, Issue 6, Pages (December 2012)
Presentation transcript:

Volume 21, Issue 11, Pages 3040-3048 (December 2017) Integrating Extracellular Flux Measurements and Genome-Scale Modeling Reveals Differences between Brown and White Adipocytes  Alfred K. Ramirez, Matthew D. Lynes, Farnaz Shamsi, Ruidan Xue, Yu-Hua Tseng, C. Ronald Kahn, Simon Kasif, Jonathan M. Dreyfuss  Cell Reports  Volume 21, Issue 11, Pages 3040-3048 (December 2017) DOI: 10.1016/j.celrep.2017.11.065 Copyright © 2017 The Authors Terms and Conditions

Cell Reports 2017 21, 3040-3048DOI: (10.1016/j.celrep.2017.11.065) Copyright © 2017 The Authors Terms and Conditions

Figure 1 Schematic Representation of Integrative Modeling (A) The Seahorse XF Analyzer directly measures the oxygen consumption rate (OCR) and extracellular acidification rate/proton production rate (ECAR/PPR) (red), indirectly measures intracellular fluxes through chemical perturbations, such as oligomycin and rotenone (green), and other fluxes are modeled via metabolic modeling and may be predicted (selected fluxes shown in black). (B) Table explaining how indirectly measured fluxes are calculated from Seahorse measurements. See also Table S2. Cell Reports 2017 21, 3040-3048DOI: (10.1016/j.celrep.2017.11.065) Copyright © 2017 The Authors Terms and Conditions

Figure 2 Measured, Predicted, and Validated Fluxes on Brown and White Adipocyte Seahorse Extracellular Flux Profiles Oxygen consumption rates (A) and proton production rates (B) were measured in response to pyruvate, oligomycin (an ATP synthase inhibitor), FCCP (a mitochondrial de-coupler), and rotenone (a complex I inhibitor). Brown adipocytes (black), compared with white adipocytes (white), showed significantly higher rates of oxygen consumption and extracellular acidification (proton production) under every injection. (C) Indirectly measured fluxes as revealed by differences in oxygen consumption rates. These extracellular flux profiles of brown and white adipocytes were integrated into the model by sampling from the data and minimizing total flux. (D–G) The model predicted higher glucose (D), glutamine (E), and palmitate (F) uptake and higher ammonia secretion (G) for brown adipocytes. (H–K) Experimentally measuring these metabolites showed consistent results for glucose (H), glutamine (I), and palmitate (J), but not for ammonia (K). Bars indicate mean ± SEM. Seahorse measurements were normalized to DNA; Nova measurements were normalized to protein; units were converted to dry weight. See also Figures S3 and S4. Cell Reports 2017 21, 3040-3048DOI: (10.1016/j.celrep.2017.11.065) Copyright © 2017 The Authors Terms and Conditions

Figure 3 Amino Acid Metabolism in Brown and White Adipocytes (A) The differences between brown and white predicted fluxes in amino acid catabolism. Red, higher in brown adipocytes; blue, higher in white; black, neither brown nor white adipocytes carried flux through those reactions. (B) The model predicted higher secretion of urea. (C) Gene expression showed an approximately 3-fold higher expression of arginase 2 in brown adipose tissue compared with white adipose tissue. (D) Urea flux was higher in brown adipocytes compared with white adipocytes. Bars indicate mean ± SEM. (E) Inhibiting arginase activity via the chemical ABH altered several key adipogenic genes in brown adipocytes, but not white adipocytes. Cell Reports 2017 21, 3040-3048DOI: (10.1016/j.celrep.2017.11.065) Copyright © 2017 The Authors Terms and Conditions

Figure 4 Reactions Predicted to Have Non-overlapping Flux Ranges between Brown and White Adipocytes (A) Top 30 reactions as revealed by flux variability analysis whose predicted extrema did not overlap between brown and white adipocytes. See also Table S1. (B–E) The non-overlapping reactions were enriched in pathways related to central metabolism and amino acid metabolism, as shown by their −log10 (FDR) (B). See also Figure S5, where flux predictions are compared with gene expression by pathway. These reactions are likely to have some distinguishing role in brown and white adipocyte biology, such as 4-aminobutyrate transaminase (C) in mitochondrial maintenance. The reactant metabolite GABA (D) and the catalyzing gene ABAT (E) were found to be higher in brown adipocytes. Bars indicate mean ± SEM. Cell Reports 2017 21, 3040-3048DOI: (10.1016/j.celrep.2017.11.065) Copyright © 2017 The Authors Terms and Conditions